Forsidebilde av showet Med wonks

Med wonks

Podkast av Dr. Matt Bezzant, MD

engelsk

Teknologi og vitenskap

Tidsbegrenset tilbud

2 Måneder for 19 kr

Deretter 99 kr / MånedAvslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Kom i gang

Les mer Med wonks

Have you ever wanted to ask your doctor a question but not had the time or opportunity to ask it? Looking for a straight answer when you ask difficult questions about healthcare? Here's your chance! Sit down with Tatumn, Krista and Dr. Matt for candid answers to your questions about healthcare, health, medicine and anything even tangentially related.

Alle episoder

3 Episoder

episode America's drug problem cover

America's drug problem

We dive into the pharmaceutical industry, so buckle up! As a side note, we reference Karendia (finerinone) as an expensive drug (around $800 a month list price) with minimal benefits. It provides 3-4% reduction in people having decreases in their GFR (a measure of kidney function) over 4 years, but no benefits in death, kidney failure, hospitalizations, heart attacks, strokes or any of the other things they measured. This is one of the medications that is being pushed on everyone with kidney disease but really is far too expensive to make sense with that little benefit. It would cost over $1,000,000 over 4 years for 1 person in 30 to not have a 40% reduction in the GFR with no other appreciable benefits. Here's the trial - https://www.nejm.org/doi/full/10.1056/NEJMoa2025845 References: https://repository.si.edu/bitstream/handle/10088/97768/Daemmrich%20PharmaMfg%20PharmHist%202017.pdf?sequence=1 [https://repository.si.edu/bitstream/handle/10088/97768/Daemmrich%20PharmaMfg%20PharmHist%202017.pdf?sequence=1] - history of pharmaceutical manufacturing https://pharmaphorum.com/r-d/a_history_of_the_pharmaceutical_industry [https://pharmaphorum.com/r-d/a_history_of_the_pharmaceutical_industry] - more history https://jamanetwork.com/journals/jama-health-forum/fullarticle/2811344 [https://jamanetwork.com/journals/jama-health-forum/fullarticle/2811344] - PBMs https://www.help.senate.gov/imo/media/doc/big_pharmas_business_model_report.pdf [https://www.help.senate.gov/imo/media/doc/big_pharmas_business_model_report.pdf] - profits in Pharma https://www.fda.gov/drugs/special-features/manufacturers-mouth-your-ears-direct-consumer-advertising [https://www.fda.gov/drugs/special-features/manufacturers-mouth-your-ears-direct-consumer-advertising] - DTC advertising https://www.propublica.org/article/doctors-prescribe-more-of-a-drug-if-they-receive-money-from-a-pharma-company-tied-to-it [https://www.propublica.org/article/doctors-prescribe-more-of-a-drug-if-they-receive-money-from-a-pharma-company-tied-to-it] - Doctors’ prescribing patterns https://lowninstitute.org/more-than-half-of-doctors-receive-industry-payments-with-some-making-millions/ [https://lowninstitute.org/more-than-half-of-doctors-receive-industry-payments-with-some-making-millions/] - industry payments https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378 [https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378] - drug research money source https://www.raps.org/news-and-articles/news-articles/2019/4/how-biopharma-companies-use-nih-and-vice-versa [https://www.raps.org/news-and-articles/news-articles/2019/4/how-biopharma-companies-use-nih-and-vice-versa] - NIH royalties https://www.gao.gov/prescription-drug-spending [https://www.gao.gov/prescription-drug-spending] - Govt prescription spending https://oig.hhs.gov/reports-and-publications/featured-topics/drug-spending/ [https://oig.hhs.gov/reports-and-publications/featured-topics/drug-spending/] - Govt drug spending https://www.aafp.org/pubs/afp/afp-community-blog/entry/will-the-high-price-of-gene-therapy-for-sickle-cell-disease-put-this-cure-out-of-reach.html#:~:text=The%20approval%20of%20Casgevy%2C%20which,distributional%20cost%2Deffectiveness%20analysis%20standards [https://www.aafp.org/pubs/afp/afp-community-blog/entry/will-the-high-price-of-gene-therapy-for-sickle-cell-disease-put-this-cure-out-of-reach.html#:~:text=The%20approval%20of%20Casgevy%2C%20which,distributional%20cost%2Deffectiveness%20analysis%20standards]. - sickle cell example https://www.fiercepharma.com/pharma/top-20-pharma-companies-2023-revenue [https://www.fiercepharma.com/pharma/top-20-pharma-companies-2023-revenue] - Pharma Revenue https://www.npr.org/2024/04/12/1244509038/u-s-drug-makers-see-big-profits-but-many-pay-taxes-far-below-the-corporate-rate [https://www.npr.org/2024/04/12/1244509038/u-s-drug-makers-see-big-profits-but-many-pay-taxes-far-below-the-corporate-rate] - drug company taxes https://www.gao.gov/products/gao-18-40 [https://www.gao.gov/products/gao-18-40] - drug company profit margins https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690298/ [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690298/] - History of drug advertising https://www.pharmacytimes.com/view/are-pbms-downplaying-their-profits [https://www.pharmacytimes.com/view/are-pbms-downplaying-their-profits] - PBM profits https://www.nbcnews.com/health/health-news/gaming-us-patent-system-keeping-drug-prices-sky-high-report-says-rcna47507 [https://www.nbcnews.com/health/health-news/gaming-us-patent-system-keeping-drug-prices-sky-high-report-says-rcna47507] - “Evergreening” and patent thickets

18. des. 2024 - 1 h 33 min
episode Follow the money cover

Follow the money

Tatumn, Krista and Matt cover a broad overview of the perverse incentives in American healthcare and the many parties involved in making it happen. Resources: https://www.commonwealthfund.org/publications/fund-reports/2024/sep/mirror-mirror-2024?utm_source=twitter&utm_medium=social&utm_campaign=Improving+Health+Care+Quality [https://www.commonwealthfund.org/publications/fund-reports/2024/sep/mirror-mirror-2024?utm_source=twitter&utm_medium=social&utm_campaign=Improving+Health+Care+Quality] - America vs peer countries https://data.worldbank.org/indicator/SP.DYN.LE00.IN?end=2022&most_recent_value_desc=true&start=1960&view=chart [https://data.worldbank.org/indicator/SP.DYN.LE00.IN?end=2022&most_recent_value_desc=true&start=1960&view=chart] - world bank life expectancy  https://www.pgpf.org/blog/2024/08/how-does-the-us-healthcare-system-compare-to-other-countries#:~:text=In%202022%2C%20the%20United%20States,per%20capita%20across%20similar%20countries [https://www.pgpf.org/blog/2024/08/how-does-the-us-healthcare-system-compare-to-other-countries#:~:text=In%202022%2C%20the%20United%20States,per%20capita%20across%20similar%20countries]. - US spending per capita  https://www.definitivehc.com/blog/the-difference-between-non-profit-and-for-profit-hospitals [https://www.definitivehc.com/blog/the-difference-between-non-profit-and-for-profit-hospitals] - non-profit vs for-profit hospitals https://lowninstitute.org/the-rising-danger-of-private-equity-in-healthcare/ [https://lowninstitute.org/the-rising-danger-of-private-equity-in-healthcare/] - private equity https://www.jabfm.org/content/early/2024/08/30/jabfm.2024.240187R0 [https://www.jabfm.org/content/early/2024/08/30/jabfm.2024.240187R0] - EHR burnout https://www.reuters.com/legal/litigation/healthcare-software-giant-epic-hit-with-lawsuit-over-us-patient-records-2024-09-23/ [https://www.reuters.com/legal/litigation/healthcare-software-giant-epic-hit-with-lawsuit-over-us-patient-records-2024-09-23/] - Epic lawsuit https://www.pgpf.org/blog/2023/04/almost-25-percent-of-healthcare-spending-is-considered-wasteful-heres-why [https://www.pgpf.org/blog/2023/04/almost-25-percent-of-healthcare-spending-is-considered-wasteful-heres-why] - waste in healthcare https://www.ama-assn.org/press-center/press-releases/ama-studies-show-continued-cost-burden-medical-liability-system [https://www.ama-assn.org/press-center/press-releases/ama-studies-show-continued-cost-burden-medical-liability-system] - malpractice burden on physicians https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048809/ [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048809/] - costs of litigation

23. okt. 2024 - 1 h 10 min
episode The doctor can't see you now cover

The doctor can't see you now

Dive into the primary care crisis with Tatumn, Krista and Dr. Matt. We discuss why it's so hard to get in to see a doctor and things fueling the primary care crisis in America. Links to research/resources: https://www.ecgmc.com/insights/whitepaper/the-waiting-game-new-patient-appointment-access-for-us-physicians [https://www.ecgmc.com/insights/whitepaper/the-waiting-game-new-patient-appointment-access-for-us-physicians] - appointment waiting times https://www.jucm.com/pros-and-cons-of-urgent-care-vs-primary-care-billing-for-urgent-care-services/ [https://www.jucm.com/pros-and-cons-of-urgent-care-vs-primary-care-billing-for-urgent-care-services/] - Cost of Urgent Care https://www.debt.org/medical/emergency-room-urgent-care-costs/ [https://www.debt.org/medical/emergency-room-urgent-care-costs/] - Urgent care vs ER costs https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/state-of-primary-care-workforce-2023.pdf [https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/state-of-primary-care-workforce-2023.pdf] - Primary care shortage https://link.springer.com/article/10.1007/s11606-022-07707-x [https://link.springer.com/article/10.1007/s11606-022-07707-x] - time for primary care visits https://www.jabfm.org/content/29/4/496.full [https://www.jabfm.org/content/29/4/496.full] - panel sizes https://jamanetwork.com/journals/jama-health-forum/fullarticle/2802144 [https://jamanetwork.com/journals/jama-health-forum/fullarticle/2802144] - appointment times https://www.usnews.com/news/best-states/articles/2020-03-17/10-states-with-the-longest-emergency-room-wait-times [https://www.usnews.com/news/best-states/articles/2020-03-17/10-states-with-the-longest-emergency-room-wait-times] - ER wait times

23. okt. 2024 - 50 min
Registrer deg for å lytte
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Tidsbegrenset tilbud

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

2 Måneder for 19 kr
Deretter 99 kr / Måned

Kom i gang

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Kom i gang

2 Måneder for 19 kr. Deretter 99 kr / Måned. Avslutt når som helst.